Partner Article
Northwich Veterinary pharmaceutical company report gross profit up 5%
Northwich based veterinary pharmaceutical business Dechra Pharmaceuticals PLC report gross profit is up 5% at £56.9 million.
The cheshire based company released its half yearly report today, reporting strong revenue growth however profits have been influenced by strong currency headwinds.
The company report that currency problems will continue to affect its financial performance throughout the year.
The group have continued its expansion plans opening in Italy in March 2014 and begining trading in Canada in January 2015.
Chief Executive Officer, Ian Page, said: “The Group has made a solid start to the year with continued momentum in Europe and a strong performance in the US.
“Our focus on executing our strategy is delivering value to shareholders.
“Our core portfolio demonstrates growth, our product pipeline is delivering results and our global expansion is progressing well.”
This was posted in Bdaily's Members' News section by Sophia Taha .
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome
The rise of an alternative investor model